The Argumentum Pharma company has begun construction of an enterprise in the Dubna SEZ, which will produce medicines, including those included in the list of vital and essential drugs. The total investment volume is more than 1.8 billion rubles.
Currently, builders have erected the columns and frame of the building. Complete the construction and put into operation the first stage of the research and production complex with an area of over 6,500 square meters. m is planned until the end of the second quarter of 2025.
At the enterprise in the Dubna SEZ, the company will produce medicines that are intended to stabilize blood pressure, treat arrhythmia, tachycardia, and myocardial infarction. It will also produce analgesics, including long-acting ones, and drugs intended for the treatment of rheumatic and oncological diseases.
At the first stage, the company will be able to produce more than 55 million units of medicines per year. The enterprise will create over 100 jobs, and with the launch of the second phase, the staff will be increased. The project on the territory of the Dubna SEZ will be implemented with the assistance of the Moscow Region Development Corporation (KRMO).